Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Other Non-Current Assets data on file, last reported at $203000.0 in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $203000.0, down 99.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $203000.0 (down 99.1% YoY), and the FY2025 annual result was $206000.0, down 99.09% from the prior year.
• Other Non-Current Assets fell to $203000.0 in Q1 2026 per DTIL's latest filing, from $206000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $26.3 million in Q3 2025 and troughed at $203000.0 in Q1 2026.
• A 5-year average of $8.4 million and a median of $3.7 million in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets jumped 9930.67% in 2024, then plunged 99.1% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $12.3 million in 2022, then plunged by 98.18% to $225000.0 in 2023, then jumped by 9930.67% to $22.6 million in 2024, then sank by 99.09% to $206000.0 in 2025, then dropped by 1.46% to $203000.0 in 2026.
• Business Quant data shows DTIL's Other Non-Current Assets at $203000.0 in Q1 2026, $206000.0 in Q4 2025, and $26.3 million in Q3 2025.